Bioverge

Bioverge is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life. The firm was founded in 2016 by Neil J. Littman and Rick Gibb-longtime industry and investment professionals with deep domain expertise who grasp the complexities of operating within a highly regulated and complex industry. Bioverge's investment thesis spans the intersection of Health + Tech has built a portfolio of 23 companies and has participated in 11 follow-on rounds for its portfolio companies, many of which are supported by some of the world's top-performing venture capital firms. Key among the Company's offerings is access to the Bioverge Network, a consortium of functional specialists capable of supporting scientific and technical founders alongside experts to source and conduct diligence on new investment opportunities.